Oocyte cryopreservation: Where are we now?

Human Reproduction Update

Volumn 22, Issue 4, 2016, Pages 440-449

  Argyle, Catrin E ^a   Harper, Joyce C ^a   Davies, Melanie C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

ART; Egg freezing; Fertility preservation; Oocyte cryopreservation; Oocyte vitrification

Indexed keywords

ARTICLE; ATTITUDE; CANCER PATIENT; CRYOPRESERVATION; EMBRYO CRYOPRESERVATION; FEMALE FERTILITY; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FOLLOW UP; FREEZING; HISTORY; HUMAN; INFERTILITY THERAPY; OOCYTE; OOCYTE CRYOPRESERVATION; OOCYTE DONATION; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; VITRIFICATION; ETHICS; FEMALE; PREGNANCY; PROCEDURES;

CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMANS; OOCYTE DONATION; OOCYTES; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84976385043     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmw007     Document Type: Article

References (151)

1. Akin JW, Bell KA, Thomas D, Boldt J. Initial experiencewith a donor egg bank. Fertil Steril 2007;88:e1-e4.
2. Almodin CG, Minguetti-Camara VC, Paixao CL, Pereira PC. Embryo development and gestation using fresh and vitrified oocytes. Hum Reprod 2010;25:1192-1198.
3. American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2008; 90:S241-S246.
4. American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013;99:37-43.
5. Antinori M, Licata E, Dani G, Cerusico F, Versaci C, Antinori S. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod Biomed Online 2007;14:72-79.
6. Baldwin K, Culley L, Hudson N, Mitchell H. Reproductive technology and the life course: current debates and research in social egg freezing. Hum Fertil 2014; 17:170-179.
7. Baldwin K, Culley L, Hudson N, Mitchell H, Lavery S. Oocyte cryopreservation for social reasons: demographic profile and disposal intentions of UK users. Reprod Biomed Online 2015;31:239-245.
8. Barritt J, Luna M, Duke M, Grunfeld L, Mukherjee T, Sandler B, Copperman AB. Report of four donor-recipient oocyte cryopreservation cycles resulting in high pregnancy and implantation rates. Fertil Steril 2007;87:e13-e17.
9. Bayliss F. Left out in the cold: arguments against non-medical oocyte cryopreservation. J Obstet Gynaecol Can 2015;37:64-67.
10. Benagiano G, Gianaroli L. The new Italian IVF legislation. Reprod Biomed Online 2004; 9:117-125.
11. Bernard A, Fuller BJ. Cryopreservation of human oocytes: current problems and perspectives. Hum Reprod 1996;2:193-207.
12. Bianchi V, Coticchio G, Distratis V, Di Giusto N, Flamigni C, Borini A. Differential sucrose concentration during dehydration (0.2 mol/l) and rehydration (0.3 mol/l) increases the implantation rate of frozen human oocytes. Reprod Biomed Online 2007;14:64-71.
13. Boldt J, Cline D, McLaughlin D. Human oocyte cryopreservation as an adjunct to IVF- embryo transfer cycles. Hum Reprod 2003;18:1250-1255.
14. Boldt J, TidswellN, SayersA, Kilani R, Cline D. Human oocyte cryopreservation: 5-year experience with a sodium-depleted slow freezing method. Reprod Biomed Online 2006;13:96-100.
15. Bonetti A, Cervi M, Tomei F, Marchini M, Ortolani F, Manno M. Ultrastructural evaluation of human metaphase II oocytes after vitrification: closed versus open devices. Fertil Steril 2011;95:928-935.
16. Borini A, Bonu MA, Coticchio G, Bianchi V, Cattoli M, Flamigni C. Pregnancies and births after oocyte cryopreservation. Fertil Steril 2004;82:601-605.
17. Borini A, Sciajno R, Bianchi V, Sereni E, Flamigni C, Coticchio G. Clinical outcome of oocyte cryopreservation after sloe cooling with a protocol utilizing a high sucrose concentration. Hum Reprod 2006;21:512-517.
18. Borini A, Levi Setti PE, Anserini P, De Luca R, De Santis L, Porcu E, La Sala GB, Ferraretti A, Bartolotti T, Coticchio G, et al. Multicenterobservational studyon slow-coolingoocyte cryopreservation: clinical outcome. Fertil Steril 2010;94:1662-1668.
19. Brison D, Cutting R, Clarke H, Wood M. ACE consensus meeting report: oocyte and embryo cryopreservation Sheffield 17.05.11. Hum Fertil 2012;15:69-74.
20. Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril 2013; 100:1673-1680.
21. Cao Y, Xing Q, Li L, Cong L, Zhang Z, Wei Z, Zhou P. Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification. Fertil Steril 2009;92:1306-1311.
22. Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1986;1:884-886.
23. Chen C. Pregnancies after human oocyte cryopreservation. Ann N Y Acad Sci 1988; 541:541-549.
24. Chian R, Huang JYJ, Tan SL, Lucena E, Saa A, Rojas A, Castellón LAR, Amador MIG, Sarmiento JEM. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod Biomed Online 2008;16:608-610.
25. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011;96:277-285.
26. Cobo A, Kuwayama M, Pérez S, Ruiz A, Pellicer A, Remohí J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008;89:1657-1664.
27. Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod 2010a;25:2239-2246.
28. Cobo A, Romero JLL, Pérez S, De Los Santos MJ, Meseguer M, Remohí J. Storage of human oocytes in the vapor phase of nitrogen. Fertil Steril 2010b;94:1903-1907.
29. Cobo A, Remohí J, Chang C, Nagy ZP. Oocyte cryopreservation for donor egg banking. Reprod Biomed Online 2011;23:341-346.
30. Cobo A, Garrido N, Crespo J, José R, Pellicer A. Accumulation of oocytes: a newstrategy for managing low-responder patients. Reprod Biomed Online 2012;24:424-432.
31. Cobo A, Serra V, Garrido N, Olmo I, Pellicer A, Remohi J. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil Steril 2014;102:1006-1015.e4.
32. Cobo A, GarridoN, Pellicer A, Remohi J. Six years' experience in ovumdonation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril 2015b; 104:1426-1434.e8.
33. Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocytes vitrification as an efficient option for elective fertility preservation. Fertil Steril 2015b;105:755-764.e8.
34. Criado E, Moalli F, Polentarutti N, Albani E, Morreale G, Menduni F, Levi-Setti PE. Experimental contamination assessment of a novel closed ultravitrification device. Fertil Steril 2011;95:1777-1779.
35. Daniluk JC, Koert E, Cheung A. Childless women's knowledge of fertility and assisted human reproduction: identifying the gaps. Fertil Steril 2012;97:420-426.
36. Devine K, Mumford SL, Goldman KN, Hodes-Wertz B, Druckenmiller S, Propst AM, Noyes N. Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birth. Fertil Steril 2015;103:1446-1453.
37. Dondorp WJ, De Wert GMWR. Fertility preservation for healthy women: ethical aspects. Hum Reprod 2009;24:1779-1785.
38. Donnez J, Dolmans MM. Fertility preservation in women. Nat Rev Endocrinol 2013; 9:735-749.
39. Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 2015;32:1167-1170.
40. Dunson DB, Baird DD, Colombo B. Increased infertility with age in men and women. Am J Obstet Gynecol 2004;103:51-56.
41. Elizur SE, Chian RC, Pineau CA, SonWY, Holzer HEG, Huang JYJ, Gidoni Y, Levin D, Demirtas E, Tan SL. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents. Rheumatology 2008;47:1506-1509.
42. Elizur SE, Chian R, Holzer HEG, Gidoni Y, Tulandi T, Tan SL. Cryopreservation of oocytes in a young woman with severe and symptomatic endometriosis: a new indication for fertility preservation. Fertil Steril 2009;91:293.e1-293.e3.
43. Emery M, Senn A, Wisard M, Germond M. Ejaculation failure on the day of oocyte retrieval for IVF: Case report. Hum Reprod 2004;19:2088-2090.
44. ESHRETask Force on Ethics and Law. Ethical considerations for the cryopreservation of gametes and reproductive tissues for self use. Hum Reprod 2004;19:460-462.
45. ESHRE Task Force on Ethics and Law. Oocyte cryopreservation for age-related fertility loss. Hum Reprod 2012;27:1231-1237.
46. Ethics committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005;83:1622-1628.
47. Fabbri R, Porcu E, Marsella T, Primavera MR, Seracchioli R, Ciotti PM, Magrini O, Venturoli S, Flamigni C. Oocyte cryopreservation. Hum Reprod 1998;13:98-108.
48. Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod 2001; 16:411-416.
49. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7:1342-1346.
50. Fadini R, Brambillasca F, Mignini Renzini M, Merola M, Comi R, De Ponti E, Dal Canto MB. Human oocyte cryopreservation: comparison between slow and ultrarapid methods. Reprod Biomed Online 2009;19:171-180.
51. Fleischer RT, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv 2011;66:248-254. Freedom of Information Act. Chapter 36. 2000, http://www.legislation.gov.uk/ ukpga/2000/36 (30 August 2015, date last accessed).
52. Fuller BJ, Hunter JE, Bernard AG, McGrath JJ, Curtis P, Jackson A. The permeability of unfertilised oocytes to 1,2-propanediol: a comparison of mouse and human cells. Cryo Letters 1992;13:287-292.
53. Garcia-Velasco JA, Domingo J, Cobo A, Martínez M, Carmona L, Pellicer A. Five years' experience using oocyte vitrification to preserve fertility formedical and nonmedical indications. Fertil Steril 2013;99:1994-1999.
54. Glenister PH, Wood MJ, Kirby C, Whittingham DG. Incidence of chromosome anomalies in first-cleavage mouse embryos obtained from frozen-thawed oocytes fertilized in vitro. Gamete Res 1987;16:205-216.
55. GlujovskyD, Riestra B, Sueldo C, FiszbajnG, Repping S, Nodar F, Papier S, Ciapponi A. Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database Syst Rev 2014. Issue 9. Art. No.: CD010047. doi:10.1002/ 14651858.CD010047.pub2.
56. Gook DA, Osborn SM, Bourne H, Johnston WIH. Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosomes. Hum Reprod 1994;9:684-691.
57. Goold I, Savulescu J. In favour of freezing eggs for non-medical reasons. Bioethics 2009; 23:47-58.
58. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005; 11:391-410.
59. Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril 2010;93:391-396.
60. Habbema JDF, Eijkemans MJC, Leridon H, Te Velde ER. Realizing a desired family size: when should couples start? Hum Reprod 2015;30:2215-2221.
61. Harwood K. Egg freezing: a breakthrough for reproductive autonomy? Bioethics 2009; 23:39-46.
62. Hashiloni-Dolev Y, Kaplan A, Shkedi-Rafid S. The fertility myth: Israeli students' knowledge regarding age-related fertility decline and late pregnancies in an era of assisted reproduction technology. Hum Reprod 2011;26:3045-3053.
63. Hirshfeld-Cytron J, Grobman WA, Milad MP. Fertility preservation for social indications: a cost-based decision analysis. Fertil Steril 2012;97:665-670.
64. Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility? Fertil Steril 2013;100:1343-1349.
65. Hoekman EJ, Smit VT, Fleming TP, Louwe LA, Fleuren GJ, Hilders CG. Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach. Fertil Steril 2015;103:469-477.
66. Homburg R, Van der Veen F, Silber SJ. Oocyte vitrification-Women's emancipation set in stone. Fertil Steril 2009;91:1319-1320.
67. Hook EB. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 1981;58:282-285.
68. Huang JYJ, Tulandi T, Holzer H, Tan SL, Chian R. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008;89:567-572.
69. Human Fertilisation and EmbryologyAuthority. Code of Practice:8th Edition. 2015, http:// www.hfea.gov.uk/docs/HFEA_Code_of_Practice:8th_Edtion_(Apr_2015).pdf (7 September 2015, date last accessed).
70. Hunter JE, Bernard A, Fuller BJ, McGrath JJ, Shaw RW. Measurements of themembrane water permeability (Lp) and its temperature dependence (activation energy) in human fresh and failed-to-fertilize oocytes and mouse oocytes. Cryobiology 1992a; 29:240-249.
71. Hunter JE, Bernard A, Fuller BJ, McGrath JJ, Shaw RW. Plasma membrane water permeabilities of human oocytes: the temperature dependence of water movement in individual cells. JCellPhysiol 1992b;150:175-179.
72. JohnsonMH, Pickering SJ, George MA. The influence of cooling on the properties of the zona pellucida of the mouse oocyte. Hum Reprod 1988;3:383-387.
73. Joly C, Bchini O, Boulekbache H, Testart J, Maro B. Effects of 1,2-propanediol on the cytoskeletal organization of the mouse oocyte. Hum Reprod 1992;7:374-378.
74. Joseph KS, Allen AC, Dodds L, Turner LA, Scott H, Liston R. The perinatal effects of delayed childbirth. Obstet Gynecol 2005;105:1410-1418.
75. Kawwass JF, Monsour M, Crawford S, Kissin DM, Session DR, Kulkarni AD, Jamieson DJ. Trends and outcomes for donor oocyte cycles in the United States, 2000-2010. JAMA 2013;310:2426-2434.
76. KazemR, Thompson LA, Srikantharajah A, Laing MA, Hamilton MPR, Templeton A. Cryopreservation of human oocytes and fertilization by two techniques: in vitro fertilization and intracytoplasmic sperm injection. Hum Reprod 1995; 10:2650-2654.
77. Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril 2006;85:1-11.
78. Kim SS, Klemp J, Fabian C. Breast cancer and fertility preservation. Fertil Steril 2011a; 95:1535-1543.
79. Kim MK, Lee DR, Han JE, Kim YS, Lee WS, Won HJ, Kim JW, Yoon TK. Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bonemarrowtransplantation. J Assist Reprod Genet 2011b;28:1167-1170.
80. Kim J, Oktay K, Gracia C, Lee S, Morse C, Mersereau JE. Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer. Fertil Steril 2012;97:671-676.
81. Kneale D, Joshi H. Postponement and childlessness: Evidence fromtwo British cohorts. Demogr Res 2008;19:1935-1968.
82. Knopman JM, Noyes N, Grifo JA. Cryopreserved oocytes can serve as the treatment for secondary infertility: a novel model for egg donation. Fertil Steril 2010a; 93:2413.e7-2413.e9.
83. Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive-agemalignancy: effects on fertility and future parenthood. Lancet Oncol 2010b;11:490-498.
84. Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A. Birth following vitrification of a small number of human oocytes. Hum Reprod 1999;14:3077-3079.
85. Kushnir VA, Barad DH, Albertini DF, Darmon SK, Gleicher N. Outcomes of fresh and cryopreserved oocyte donation. JAMA 2015;314:623-624.
86. Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005;11:300-308.
87. Lampic C, Skoog Svanberg A, Karlström P, Tydén T. Fertility awareness, intentions concerning childbearing, and attitudes towards parenthood among female and male academics. Hum Reprod 2006;21:558-564.
88. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-2931.
89. Lee S, Ozkavukcu S, Heytens E, Oktay K. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol 2010;28:4683-4686.
90. Lee S, Heytens E, Moy F, Ozkavukcu S, Oktay K. Determinants of access to fertility preservation in women with breast cancer. Fertil Steril 2011;95:1932-1936.
91. Leibo SP, Pool TB. The principal variables of cryopreservation: solutions, temperatures, and rate changes. Fertil Steril 2011;96:269-276.
92. Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod 2004;19:1548-1553.
93. Levi Setti PE, Albani E, Novara PV, Cesana A, Morreale G. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 2006;21:370-375.
94. Li X, Chen S, Zhang X, Tang M, Kui Y, Wu X, Wang S, Guo Y. Cryopreservedoocytes of infertile couples undergoing assisted reproductive technology could be an important source of oocyte donation: a clinical report of successful pregnancies. Hum Repord 2005;20:3390-3394.
95. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005; 353:64-73.
96. Lockwood GM. Social egg freezing: the prospect of reproductive 'immortality' or a dangerous delusion? Reprod Biomed Online 2011;23:334-340.
97. Magli MC, Lappi M, Ferraretti AP, Capoti A, Ruberti A, Gianaroli L. Impact of oocyte cryopreservation on embryo development. Fertil Steril 2010;93:510-516.
98. Martinez M, Rabadan S, Domingo J, Cobo A, Pellicer A, Garcia-Velasco JA. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. Reprod Biomed Online 2014;29:722-728.
99. Mazur P, Seki S. Survival ofmouse oocytes after being cooled in a vitrification solution to 21958Cat95 8Cto 70,0008Cpermin andwarmed at 6108Cto 118,0008Cpermin. A new paradigm for cryopreservation by vitrification. Cryobiology 2011;62:1-7.
100. Nagy ZP, Chang C, Shapiro DB, Bernal DP, Elsner CW, Mitchell-Leef D, Toledo MD, KortHI. Clinical evaluation of the efficiency of an oocyte donation programusing egg cryo-banking. Fertil Steril 2009;92:520-526.
101. National Institute for Health and Clinical Excellence (NICE). Fertility: Assessment and Treatment for People with Fertility Problems, CG156. London: National Institute for Health and Clinical Excellence, 2013.
102. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, Grunfeld L. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991;337:1375-1377.
103. Noyes N, Porcu E, Borini A. Over 900 cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 2009;18:769-776.
104. Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online 2011;23:323-333.
105. Nybo Anderson A, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000;320:1708-1712.
106. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a metaanalysis. Fertil Steril 2006;86:70-80.
107. Oktay K, Buyuk E, Rodriguez-Wallberg KA, SahinG. In vitromaturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 2010;20:634-638.
108. Paffoni A, Guarneri C, Ferrari S, Restelli L, Nicolosi AE, Scarduelli C, Ragni G. Effects of two vitrification protocols on the developmental potential of human mature oocytes. Reprod Biomed Online 2011;22:292-298.
109. Papatheodorou A, Vanderzwalmen P, Panagiotidis Y, Prapas N, Zikopoulos K, Georgiou I, Prapas Y. Open versus closed oocyte vitrification system: a prospective randomized sibling-oocyte study. Reprod Biomed Online 2013;26:595-602.
110. Parmegiani L, Accorsi A, Cognigni GE, Bernardi S, Troilo E, Filicori M. Sterilization of liquid nitrogen with ultraviolet irradiation for safe vitrification of human oocytes or embryos. Fertil Steril 2010;94:1525-1528.
111. Parmegiani L, Cognigni GE, Bernardi S, Cuomo S, Ciampaglia W, Infante FE, Tabarelli de Fatis C, Arone A, Maccarini AM, Filicori M. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed Online 2011;23:505-512.
112. Paynter SJ, Cooper A, Gregory L, Fuller BJ, Shaw RW. Permeability characteristics of human oocytes in the presence of the cryoprotectant dimethylsulphoxide. Hum Reprod 1999;14:2338-2342.
113. Pennings G. What are the ownership rights for gametes and embryos? Hum Reprod 2000;15:979-986.
114. Pickering SJ, Johnson MH. The influence of cooling on the organization of the meiotic spindle of the mouse oocyte. Hum Reprod 1987;2:207-216.
115. Pickering SJ, Braude PR, Johnson MH, Cant A, Currie J. Transient cooling to room-temperature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril 1990;54:102-108.
116. Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril 1997;68:724-726.
117. Porcu E, Fabbri R, Ciotti PM, Marsella T, Balicchia B, Damiano G, Caracciolo D, Giunchi D, De Cesare R, Flamigni C. Cycles of human oocyte cryopreservation and intracytoplasmic sperm injection: results of 112 cycles. Fertil Steril 1999;72:S2.
118. Quaas AM, Melamed A, Chung K, Bendikson KA, Paulson RJ. Egg banking in theUnited States: current status of commercially available cryopreserved oocytes. Fertil Steril 2013;99:827-831.
119. Rao GD, Chian RC, Son WS, Gilbert L, Tan SL. Fertility preservation in women undergoing cancer treatment. Lancet 2004;363:1829.
120. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors inwomen with breast cancer. Fertil Steril 2012;98:1363-1369.
121. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, Colamaria S, Sapienza F, Ubaldi F. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 2010;25:66-73.
122. Rienzi L, Cobo A, Paffoni A, ScarduelliC, Capalbo A, Vajta G, RemohíJ, RagniG, Ubaldi FM. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod 2012;27:1606-1612.
123. Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fetil Steril 2010;94:2642-2646.
124. Saragusty J, Arav A. Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reproduction 2011;141:1-19.
125. Sathananthan AH, Ng SC, Trounson AO, Bongso A, Ratnam SS, Ho J, Mok H, Lee MN. The effects of ultrarapid freezing on meiotic and mitotic spindles of mouse oocytes and embryos. Gamete Res 1988;21:385-401.
126. Sauer MV, Kavic SM. Oocyte and embryo donation. 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online 2006;12:153-162.
127. Sauer MV, Paulson RJ, Lobo RA. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990;323:1157-1160.
128. Seki S, Mazur P. The dominance of warming rate over cooling rate in the survival of mouse oocytes subjected to a vitrification procedure. Cryobiology 2009;59:75-82.
129. Smith GD, Serafini PC, Fioravanti J, Yadid I, Coslovsky M, Hassun P, Alegretti JR, Motta EL. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril 2010;94:2088-2095.
130. Solé M, Santaló J, Boada M, Clua E, Rodríguez I, Martínez F, Coroleu B, Barri PN, Veiga A. How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes. Hum Reprod 2013;28:2087-2092.
131. Song W, Sun Y, Jin H, Xin Z, Su Y, Chian R. Clinical outcome of emergency egg vitrification for women when sperm extraction from the testicular tissues of the male partner is not successful. Syst Biol Reprod Med 2011;57:210-213.
132. Sozou PD, Hartshorne GM. Time to pregnancy: a computational method. PLoS ONE 2012;7:e46544.
133. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;2:366-366.
134. Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod 2011;26:655-661.
135. Stoop D, De Munck N, Jansen E, Platteau P, Van den Abbeel E, Verheyen G, Devroey P. Clinical validation of a closed vitrification systemin an oocyte-donation programme. Reprod Biomed Online 2012;24:180-185.
136. Stoop D, Cobo A, Silber S. Fertility preservation for age-related fertility decline. Lancet 2014;384:1311-1319.
137. Stoop D, Maes E, Polyzos NP, Verheyen G, Tournaye H, Nekkebroeck J. Does oocyte banking for anticipated gamete exhaustion influence future relational and reproductive choices? A follow-up of bankers and non-bankers. Hum Reprod 2015;30:338-344.
138. Tan SQ, Tan AWK, Lau MSK, Tan HH, Nadarajah S. Social oocyte freezing: a survey among Singaporean female medical students. J Obstet Gynaecol Res 2014; 40:1345-1352.
139. Toth TL, Baka SG, Veeck LL, Jones HW Jr, Muasher S, Lanzendorf SE. Fertilization and in vitro development of cryopreserved human prophase I oocytes. Fertil Steril 1994; 61:891-894.
140. Trokoudes KM, Pavlides C, Zhang X. Comparison outcome of fresh and vitrified donor oocytes in an egg-sharing donation program. Fertil Steril 2011;95:1996-2000.
141. Tucker MJ, Morton PC, Wright G, Sweitzer CL, Massey JB. Clinical application of human egg cryopreservation. Hum Reprod 1998;13:3156-3159.
142. Ubaldi F, Anniballo R, Romano S, Baroni E, Albricci L, Colamaria S, Capalbo A, Sapienza F, Vajta G, Rienzi L. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod 2010;25:1199-1205.
143. Vajta G, Rienzi L, Ubaldi FM. Open versus closed systems for vitrification of human oocytes and embryos. Reprod Biomed Online 2015;30:325-333.
144. Van Blerkom J, Davis PW. Cytogenetic, cellular, and developmental consequences of cryopreservation of immature and mature mouse and human oocytes. Microsc ResTech 1994;27:165-193.
145. Van Loendersloot LL, Moolenaar LM, Mol BWJ, Repping S, Van der Veen F, Goddijn M. Expanding reproductive lifespan: a cost-effectiveness study on oocyte freezing. Hum Reprod 2011;26:3054-3060.
146. Van Uem JFHM, Siebzehnrübl ER, Schuh B, Koch R, Trotnow S, Lang N. Birth after cryopreservation of unfertilized oocytes. Lancet 1987;1:752-753.
147. Vincent C, Garnier V, Heyman Y, Renard JP. Solvent effects on cytoskeletal organization and in-vivo survival after freezing of rabbit oocytes. J Reprod Fertil 1989;87:809-820.
148. Vincent C, Pickering SJ, Johnson MH. The hardening effect of dimethylsulphoxide on the mouse zona pellucida requires the presence of an oocyte and is associated with a reduction in the number of cortical granules present. J Reprod Fertil 1990; 89:253-259.
149. Winslow KL, Yang D, Blohm PL, Brown SE, Jossim P, Nguyen K. Oocyte cryopreservation-a three year follow up of sixteen births. Fertil Steril 2001; 76:S120-S121.
150. Wise J. UK lifts ban on frozen eggs. BMJ 2000;320:334.
151. Ziadeh S, YahayaA. Pregnancy outcome at age 40 and older. Arch Gynecol Obstet 2001; 265:30-33.